Citations: Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update

219

Views

CrossRef citations to date

Altmetric

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Su Young Jung, Sung-A Chang, Jong-Min Song, Jae Young Choi, Hyung-Kwan Kim, Jung Hyun Choi, Jung Yeon Chin, Minseok Park, SuYoun Kim & Hyuk-Jae Chang. (2022) Real-World Safety and Clinical Outcomes of Macitentan in Asian Patients with Pulmonary Arterial Hypertension: A Prospective Multicenter Study. Drugs - Real World Outcomes 10:1, pages 41-49.
Crossref

Ali Dabbagh, Zahra Talebi & Samira Rajaei. 2023. Congenital Heart Disease in Pediatric and Adult Patients. Congenital Heart Disease in Pediatric and Adult Patients 91 152 .

Pankaj Jariwala, VenkataNagarjuna Maturu, KartikPandurang Jadhav, Arshad Punjani & Harikishan Boorugu. (2022) The clinical experience of macitentan in pulmonary hypertension in Indian cohort: 12-month follow-up. Lung India 39:1, pages 12.
Crossref

Zahra Nekoukar, Minoo Moghimi & Ebrahim Salehifar. (2021) A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities. BLOOD RESEARCH 56:4, pages 229-242.
Crossref

Anna Russignan, Giada Dal Collo, Anna Bagnato, Nicola Tamassia, Mattia Bugatti, Mirella Belleri, Luisa Lorenzi, Enrica Borsi, Riccardo Bazzoni, Michele Gottardi, Carolina Terragna, William Vermi, Arianna Giacomini, Marco Presta, Marco Antonio Cassatella, Mauro Krampera & Cristina Tecchio. (2021) Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma. Frontiers in Oncology 10.
Crossref

Marzieh Nosrati, NikinazAshrafi Shahmirzadi, Monireh Afzali, Pardis Zaboli, Hasti Rouhani, Haleh Hamedifar & Mirhamed Hajimiri. (2020) Cost-utility analysis of Macitentan Vs. Bosentan in pulmonary atrial hypertension. Journal of Family Medicine and Primary Care 9:7, pages 3634.
Crossref

Dunbar Ivy, Maurice Beghetti, Ernesto Juaneda-Simian, Diane Miller, Mary Ann Lukas, Chris Ioannou, Malek Okour, Jun Narita & Rolf M.F. Berger. (2020) A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients Aged 8 Years up to 18 Years. The Journal of Pediatrics: X 5, pages 100055.
Crossref

Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date